Katsimardou, A.; Theofilis, P.; Vordoni, A.; Doumas, M.; Kalaitzidis, R.G.
The Effects of SGLT2 Inhibitors on Blood Pressure and Other Cardiometabolic Risk Factors. Int. J. Mol. Sci. 2024, 25, 12384.
https://doi.org/10.3390/ijms252212384
AMA Style
Katsimardou A, Theofilis P, Vordoni A, Doumas M, Kalaitzidis RG.
The Effects of SGLT2 Inhibitors on Blood Pressure and Other Cardiometabolic Risk Factors. International Journal of Molecular Sciences. 2024; 25(22):12384.
https://doi.org/10.3390/ijms252212384
Chicago/Turabian Style
Katsimardou, Alexandra, Panagiotis Theofilis, Aikaterini Vordoni, Michael Doumas, and Rigas G. Kalaitzidis.
2024. "The Effects of SGLT2 Inhibitors on Blood Pressure and Other Cardiometabolic Risk Factors" International Journal of Molecular Sciences 25, no. 22: 12384.
https://doi.org/10.3390/ijms252212384
APA Style
Katsimardou, A., Theofilis, P., Vordoni, A., Doumas, M., & Kalaitzidis, R. G.
(2024). The Effects of SGLT2 Inhibitors on Blood Pressure and Other Cardiometabolic Risk Factors. International Journal of Molecular Sciences, 25(22), 12384.
https://doi.org/10.3390/ijms252212384